69 results on '"Baldacci, S"'
Search Results
2. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR
3. Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries
4. Respiratory/Allergic Symptoms in Italian Children Living Close to Cultivations Sprayed With Pesticides
5. Genetic and environmental influences on infant anthropometry at birth and four months of life: evidence from singleton and twin data in the HEALS and earlyFOOD projects
6. Outdoor air pollution and respiratory health
7. Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
8. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR
9. Exposure to air pollution and allergic diseases in adults
10. Air pollution exposure and prevalence of chronic respiratory diseases in Italy
11. Influence of overweight/obesity, lifestyle and grey space on asthma in Italy
12. Issue 1 - “Update on adverse respiratory effects of outdoor air pollution”. Part 1): Outdoor air pollution and respiratory diseases: A general update and an Italian perspective
13. 12-Month Follow-Up of Patients Included in the Italian Severe/Uncontrolled Asthma Registry (RItA)
14. Urban grey spaces are associated with increased allergy in the general population
15. Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
16. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques
17. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR
18. 1341P NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
19. A Population-Based Study on the Influence of Agricultural and Grey Spaces Proximity on Biomarkers of Exposure and Effect
20. Serum Antibodies Anti-Benzo(a)Pyrene Diol Epoxide-DNA Adducts (BPDE-DNA) and Tobacco Smoking May Predict Respiratory Outcomes in a General Population Follow-Up
21. The severe asthma registries: a way to better know and fight the disease
22. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ROS1+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
23. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ALK+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
24. The epidemiological link between ageing and respiratory diseases
25. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques
26. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR : quels inhibiteurs ? Quelles séquences thérapeutiques ?
27. 1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
28. 1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
29. Greater Risk of Asthma and Allergic Rhinitis, But Not Eczema, Associated with Living Close to Green Space in European Children. The Heals Project
30. Impact de la mise en place de consultations pharmaceutiques dédiées aux thérapies ciblées orales chez les patients atteints de cancer bronchique
31. Oncogenèse pulmonaire: comprendre les addictions oncogéniques et les résistances
32. Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2019
33. P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study
34. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR: quelle(s) séquence(s) ?
35. Temporal Changes in Respiratory Morbidity and Multimorbidity with Associated Risk Factors in an Italian General Population Sample
36. Efficacité des inhibiteurs de checkpoint immunitaire dans le carcinome sarcomatoïde du poumon : données issues d’une cohorte française multicentrique
37. Les mutations des sites d’épissage de l’exon 14 de MET. Une nouvelle opportunité thérapeutique dans le cancer du poumon
38. Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations
39. Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort
40. MA 07.06 Detection of Mechanisms of Resistance to ALK Inhibitors in Routine Practice: A Retrospective Study
41. Les cancers bronchiques non à petites cellules EGFR-mutés
42. Les cancers bronchiques non à petites cellules EGFR-mutés
43. L’amplification de Met est associée à un phénotype tumoral plus agressif lors de la résistance aux inhibiteurs d’EGFR dans les cancers bronchiques non à petites cellules EGFR mutés
44. Air quality of nursing homes and its effect on the lung health of elderly residents
45. Cancer bronchique
46. Allergy and asthma: Effects of the exposure to particulate matter and biological allergens
47. Cancer bronchique
48. The ARGA study with Italian general practitioners: prescriptions for allergic rhinitis and adherence to ARIA guidelines
49. Congruence between international guidelines and mite specific immunotherapy prescribing practices
50. Longitudinal assessments of habitual use of medicines in a nested case-control study of italian adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.